You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 16, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Seulki Lee1, Jin Xie, Xiaoyuan Chen
1Laboratory for Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 31 Center Drive, Suite 1C14, Bethesda, Maryland 20892-2281, USA.
Peptide-based imaging probes offer precise disease diagnosis by targeting specific biomarkers. Advances in phage display and bioconjugation enhance their efficiency for in vivo molecular imaging applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: